Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ferumoxytol Enhanced Magnetic Resonance Imaging of Type 1 Diabetes Progression

NCT01521520 is registered in ClinicalTrials.gov with Jason Gaglia as lead sponsor.

NCT NCT01521520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01521520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ferumoxytol Enhanced Magnetic Resonance Imaging of Type 1 Diabetes Progression
Lead sponsor
Jason Gaglia
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2012
Completion date
Not reported
Enrollment
65 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes